3 assets in Ovarian Clear Cell Tumor

Therapeutic assets addressing Ovarian Clear Cell Tumor, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
nxp800 Ovarian Clear Cell Tumor	Nuvectis Pharma, Inc.	P1	CC (43)
Pembrolizumab Ovarian Clear Cell Tumor	HonorHealth Research Institute	P1	CC (43)
Seclidemstat Ovarian Clear Cell Tumor	HonorHealth Research Institute	P1	CC (43)